Pages
All Departments
Let's get Social
Copyright Here. All rights reserved.
BYWWW.NEJM.ORGJuly 14, 2017
Methods . We conducted a phase 1, dose-escalating trial of STI571 (formerly known as CGP 57148B), a specific inhibitor of the BCR-ABL tyrosine kinase.